Featured Articles

1. RWD, New Technologies Show Potential In Clinical Trial Recruitment 7/10/2025

   Leveraging RWD transforms feasibility and recruitment from reactive processes into strategic drivers of clinical trial success.

2. Clinical Trials Need To Take The Whole Patient Into Account 7/10/2025

   Explore how inclusivity in clinical trials needs to encompass the whole patient, taking into account factors like race, sex, age, ethnicity, sexual orientation, and physical abilities or qualities.

3. Use Case: How Consulting & Analytics Can Guide Clinical Strategy 7/10/2025

   A large European pharmaceutical company sought to benchmark a CRO’s suggestions involving a Phase III trial for a newly acquired asset.

4. 8 Tips For Producing Masterful Plain Language Summaries 7/10/2025

   Following these tips will ensure high-quality plain language summaries (PLS) that meet EU parameters while clearly communicating clinical trial information to patients and the public.

5. Sickle Cell Cure Within Reach, But At A Steep Cost 7/10/2025

   Treatment options for sickle cell disease (SCD) and newly available gene therapies represent a potential cure. However, the latter are costly and thus remain out of reach for many SCD patients.

6. Disclosure Management System: Build Or Buy? 6/19/2025

   Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution.

7. New Data Sources Can Help Pharma Meet Challenges 6/19/2025

   Claire Riches, Citeline VP of Clinical Solutions, discussed the changing pharma landscape and data options, such as RWD, RWE, and AI at Citeline Elevate Spring 2025.

8. Completed Clinical Trials Continued To Climb In 2024 6/19/2025

   Data collected in this report reflects a shift toward sustained growth, reflecting rapid advancement in therapeutic areas such as oncology, autoimmune/inflammation, and central nervous system studies.

9. Data Key In Addressing Patient Recruitment Challenges 6/19/2025

   Explore how a Phase II trial for extensive-stage and previously treated small cell lung cancer overcame recruitment challenges with a data-driven solution designed to surface protocol-matched patients.

10. Zeroing In On The Right Patients With RWD & Proprietary Data 4/28/2025

    Complex I/E criteria? Seeking broad demographic representation? Don’t know where to find eligible patients? No problem! See how comprehensive data and a connected ecosystem combine to revamp recruitment.